Mastodon

Boracidum (Solution) Instructions for Use

Marketing Authorization Holder

Kirov Pharmaceutical Factory, JSC (Russia)

ATC Code

D11AF (Drugs for the treatment of calluses and warts)

Dosage Form

Bottle OTC Icon Boracidum Solution for external use 392 mg/g+588 mg/g

Dosage Form, Packaging, and Composition

Solution for external use

Metacresol 392 mg/g
Phenol 588 mg/g

10 g – bottles – cardboard packs – Over-the-Counter
10 g – bottles – cardboard packs /with a cap with an applicator/brush applicator/pipette applicator/spatula/ – Over-the-Counter
2 g – bottles – cardboard packs – Over-the-Counter
2 g – bottles – cardboard packs /with a cap with an applicator/brush applicator/pipette applicator/spatula/ – Over-the-Counter

Clinical-Pharmacological Group

Drug with cauterizing and mummifying action

Pharmacotherapeutic Group

Other preparations for the treatment of skin conditions; preparations for the treatment of calluses and warts

Pharmacological Action

A combined medicinal product for external use. It has a cauterizing action, coagulating skin proteins.

Indications

Common, filiform, and plantar warts; papillomas; skin condylomata acuminata; dry calluses; keratomas.

ICD codes

ICD-10 code Indication
A63.0 Anogenital [venereal] warts (condyloma acuminatum)
B07 Viral warts
D23 Other benign neoplasms of skin
L84 Corns and callosities
ICD-11 code Indication
1A95.Z Anogenital warts, unspecified
1E80.Z Common warts, unspecified
1E81 Flat warts
1E83 Spread of wart virus in immunodeficiency states
1E8Z Viral warts, not elsewhere classified
2F2Z Benign neoplasm of skin, unspecified type
EH92.0Z Callosity, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

For external use only.

Apply the solution precisely to the affected area using the provided applicator, a small wooden stick, or a cotton swab.

Avoid any contact with adjacent healthy skin and mucous membranes.

For common warts, apply a minimal amount once daily for 2-3 days until the lesion turns yellow.

For plantar warts, after preliminary softening and removal of the horny layer, apply the solution once daily for 4-5 days.

For dry calluses, apply once daily for 2-3 days.

For keratomas, apply once daily for 7-10 days.

Allow the applied solution to air dry completely.

Do not wash the treated area or apply ointments on the day of application.

Do not bandage, cover with a plaster, or forcibly remove the resulting scab.

The interval between treatment courses must be at least 7 days.

The total treated surface area must not exceed 20 cm².

If severe pain, redness, or swelling occurs, discontinue use immediately and seek medical advice.

Adverse Reactions

Possible burn (if it gets on healthy skin), swelling and redness of the skin when applied in the eye area, which resolve on their own; allergic reactions.

Contraindications

Hypersensitivity to the components of the combination; pigmented nevi (moles); rashes located on the red border of the lips and mucous membranes; the product must not be applied to a skin surface area exceeding 20 cm2; children under 7 years of age.

Use in Pregnancy and Lactation

Use during pregnancy and breastfeeding is possible in cases where the intended benefit to the mother outweighs the potential risk to the fetus or child. During lactation, it is not recommended to remove lesions located on the mammary glands and hands.

Pediatric Use

Contraindicated in children under 7 years of age.

Special Precautions

This product must not be allowed to come into contact with mucous membranes, especially the mucous membrane of the eyes. In case of contact, immediately rinse the eyes with plenty of water and consult an ophthalmologist.

It is unacceptable to bandage the treated skin areas, cover them with a plaster, smear them with any ointments, or remove the scab; this product must not be reapplied earlier than the recommended time intervals. Clothing made of synthetic fabrics should not touch the skin area treated with this product.

It is not recommended to apply this product to lesions located in skin folds (groin folds, anal area, interdigital spaces, etc.) and heavily sweating areas to avoid burns of the unaffected skin of the contacting surface or due to the product spreading on moist skin.

The treated skin area should air dry; it should not be smeared with any ointments or washed with water on the first day after treatment.

When used correctly, this product does not leave scars.

Particular care and caution are required when treating children.

Drug Interactions

The components of the combination dissolve easily in an ointment base, therefore, it is not recommended to smear the treated skin area with any ointments.

Storage Conditions

Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS